Insider Trading - Poseida Therapeutics Inc. (PSTX)

Real time insider trading transaction history:

  1. Insiders must file a Form 4 covering their trades within two business days.
  2. Section 16 prohibits insiders from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period:
Insider Trading Transactions for Poseida Therapeutics Inc.
Goto 0, 1, Next

Common stock purchase or sale:
Transaction
Date
Reported
DateTime
Company Symbol Insider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2021-02-10
Sale
2021-02-12
5:03 pm
Poseida Therapeutics Inc. PSTX Ostertag Eric
CEO
10% Owner
12,389 $10 $123,890 9,973,402
(Indirect
Direct)
View
2021-02-16
Sale
2021-02-17
5:28 pm
Poseida Therapeutics Inc. PSTX Ostertag Eric
CEO
10% Owner
133,149 $10 $1,332,036 9,840,253
(Indirect
Direct)
View
2021-03-01
Sale
2021-03-03
7:38 pm
Poseida Therapeutics Inc. PSTX Ostertag Eric
CEO
10% Owner
115,000 $11.6 $1,334,461 5,924,431
(Indirect
Direct)
View
2021-04-01
Sale
2021-04-05
7:50 pm
Poseida Therapeutics Inc. PSTX Ostertag Eric
CEO
10% Owner
115,000 $9.6087 $1,104,998 5,866,944
(Indirect
Direct)
View
2021-04-21
Sale
2021-04-23
8:49 pm
Poseida Therapeutics Inc. PSTX Spear Matthew A.
Chief Medical Officer
4,000 $8.438 $33,752 269,207
(Direct)
View
2021-05-03
Sale
2021-05-05
7:29 pm
Poseida Therapeutics Inc. PSTX Ostertag Eric
CEO
10% Owner
54,312 $8.6323 $468,839 5,843,455
(Indirect
Direct)
View
2021-06-01
Sale
2021-06-03
7:21 pm
Poseida Therapeutics Inc. PSTX Ostertag Eric
CEO
10% Owner
81,916 $8.4758 $694,302 5,804,278
(Indirect
Direct)
View
2021-06-11
Sale
2021-06-14
6:18 pm
Poseida Therapeutics Inc. PSTX Spear Matthew A.
Chief Medical Officer
4,000 $9.4368 $37,747 136,346
(Direct)
View
2021-07-01
Sale
2021-07-06
5:35 pm
Poseida Therapeutics Inc. PSTX Ostertag Eric
CEO
10% Owner
48,105 $9.275 $446,174 5,781,272
(Indirect
Direct)
View
2021-08-02
Sale
2021-08-04
4:57 pm
Poseida Therapeutics Inc. PSTX Ostertag Eric
CEO
10% Owner
33,673 $8.0471 $270,970 5,765,167
(Indirect
Direct)
View
2021-08-20
Sale
2021-08-24
5:12 pm
Poseida Therapeutics Inc. PSTX Spear Matthew A.
Chief Medical Officer
4,000 $8.7854 $35,142 132,346
(Direct)
View
2021-09-01
Sale
2021-09-03
4:54 pm
Poseida Therapeutics Inc. PSTX Ostertag Eric
CEO
10% Owner
112,411 $8.3946 $943,646 5,822,554
(Indirect
Direct)
View
2021-09-13
Sale
2021-09-15
6:58 pm
Poseida Therapeutics Inc. PSTX Ostertag Eric
CEO
10% Owner
20,000 $8.1356 $162,712 10,263,181
(Indirect
Direct)
View
2021-09-20
Sale
2021-09-22
5:51 pm
Poseida Therapeutics Inc. PSTX Ostertag Eric
CEO
10% Owner
20,000 $8.001 $160,020 9,483,661
(Indirect
Direct)
View
2021-10-01
Sale
2021-10-05
6:16 pm
Poseida Therapeutics Inc. PSTX Ostertag Eric
CEO
10% Owner
20,029 $7.02 $140,604 5,794,256
(Indirect
Direct)
View
2021-11-08
Sale
2021-11-10
6:06 pm
Poseida Therapeutics Inc. PSTX Ostertag Eric
CEO
10% Owner
18,924 $7.09 $134,171 5,806,212
(Indirect
Direct)
View
2021-11-16
Purchase
2021-11-18
8:24 pm
Poseida Therapeutics Inc. PSTX Malin Life Sciences Holdings Ltd
10% Owner
379,376 $7.201 $2,731,889 9,567,501
(Direct)
View
2021-11-17
Purchase
2021-11-18
9:12 pm
Poseida Therapeutics Inc. PSTX Ingalls Kerry D.
COO
2,000 $7 $14,000 2,000
(Direct)
View
2021-11-19
Purchase
2021-11-23
6:41 pm
Poseida Therapeutics Inc. PSTX Malin Life Sciences Holdings Ltd
10% Owner
25,729 $7.0597 $181,640 9,593,230
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
Company Symnbol Insider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2021-02-04
Option Award
2021-02-05
4:52 pm
N/A
2031-02-03
Poseida Therapeutics Inc. PSTX Gergen Mark J
President and CBO
342,000 $0 342,000
(Direct)
View
2021-02-04
Option Award
2021-02-05
4:52 pm
N/A
2031-02-03
Poseida Therapeutics Inc. PSTX Spear Matthew A.
Chief Medical Officer
164,000 $0 164,000
(Direct)
View
2021-02-04
Option Award
2021-02-05
4:53 pm
N/A
2031-02-03
Poseida Therapeutics Inc. PSTX Ingalls Kerry D.
COO
137,000 $0 137,000
(Direct)
View
2021-02-04
Option Award
2021-02-05
4:54 pm
N/A
2031-02-03
Poseida Therapeutics Inc. PSTX LEONHARDT HARRY J
GC & Chief Compliance Officer
137,000 $0 137,000
(Direct)
View
2021-02-04
Option Award
2021-02-05
4:54 pm
N/A
2031-02-03
Poseida Therapeutics Inc. PSTX Mylet Johanna
VP
82,000 $0 82,000
(Direct)
View
2021-02-10
Exercise
2021-02-12
5:03 pm
N/A
2026-02-28
Poseida Therapeutics Inc. PSTX Ostertag Eric
CEO
10% Owner
67,534 $0 9,973,402
(Direct)
View
2021-02-10
Exercise
2021-02-12
5:03 pm
N/A
N/A
Poseida Therapeutics Inc. PSTX Ostertag Eric
CEO
10% Owner
67,534 $1.29 9,973,402
(Direct)
View
2021-02-23
Exercise
2021-02-25
7:01 pm
N/A
2026-02-28
Poseida Therapeutics Inc. PSTX Ostertag Eric
CEO
10% Owner
111,395 $0 9,954,405
(Direct)
View
2021-02-23
Exercise
2021-02-25
7:01 pm
N/A
N/A
Poseida Therapeutics Inc. PSTX Ostertag Eric
CEO
10% Owner
111,395 $1.173 9,954,405
(Direct)
View
2021-04-21
Exercise
2021-04-23
8:49 pm
N/A
2026-06-19
Poseida Therapeutics Inc. PSTX Spear Matthew A.
Chief Medical Officer
9,000 $0 269,207
(Direct)
View
2021-04-21
Exercise
2021-04-23
8:49 pm
N/A
N/A
Poseida Therapeutics Inc. PSTX Spear Matthew A.
Chief Medical Officer
9,000 $1.322 269,207
(Direct)
View
2021-06-11
Exercise
2021-06-14
6:18 pm
N/A
2026-06-19
Poseida Therapeutics Inc. PSTX Spear Matthew A.
Chief Medical Officer
4,000 $0 136,346
(Direct)
View
2021-06-11
Exercise
2021-06-14
6:18 pm
N/A
N/A
Poseida Therapeutics Inc. PSTX Spear Matthew A.
Chief Medical Officer
4,000 $1.322 136,346
(Direct)
View
2021-06-16
Option Award
2021-06-17
5:03 pm
N/A
2031-06-15
Poseida Therapeutics Inc. PSTX Hirsch David
Director
20,000 $0 20,000
(Direct)
View
2021-06-16
Option Award
2021-06-17
5:03 pm
N/A
2031-06-15
Poseida Therapeutics Inc. PSTX Schmid John P.
Director
20,000 $0 20,000
(Direct)
View
2021-06-16
Option Award
2021-06-17
5:03 pm
N/A
2031-06-15
Poseida Therapeutics Inc. PSTX Lloyd Marcea Bland
Director
20,000 $0 20,000
(Direct)
View
2021-06-17
Exercise
2021-06-21
8:02 pm
N/A
2026-06-19
Poseida Therapeutics Inc. PSTX Spear Matthew A.
Chief Medical Officer
5,000 $0 136,346
(Direct)
View
2021-06-17
Exercise
2021-06-21
8:02 pm
N/A
N/A
Poseida Therapeutics Inc. PSTX Spear Matthew A.
Chief Medical Officer
5,000 $1.322 136,346
(Direct)
View
2021-07-23
Option Award
2021-07-26
8:29 pm
N/A
2031-07-23
Poseida Therapeutics Inc. PSTX Collins Cynthia
Director
87,440 $0 87,440
(Direct)
View
2021-07-23
Option Award
2021-07-26
8:30 pm
N/A
2031-07-23
Poseida Therapeutics Inc. PSTX Hirsch David
Director
25,833 $0 25,833
(Direct)
View
2021-07-23
Option Award
2021-07-26
8:31 pm
N/A
2031-07-23
Poseida Therapeutics Inc. PSTX Lloyd Marcea Bland
Director
25,833 $0 25,833
(Direct)
View
2021-07-23
Option Award
2021-07-26
8:32 pm
N/A
2031-07-23
Poseida Therapeutics Inc. PSTX Schmid John P.
Director
25,833 $0 25,833
(Direct)
View
2021-07-28
Exercise
2021-07-30
4:29 pm
N/A
2026-06-19
Poseida Therapeutics Inc. PSTX Spear Matthew A.
Chief Medical Officer
20,000 $0 136,346
(Direct)
View
2021-07-28
Exercise
2021-07-30
4:29 pm
N/A
N/A
Poseida Therapeutics Inc. PSTX Spear Matthew A.
Chief Medical Officer
20,000 $1.322 136,346
(Direct)
View
2021-08-06
Exercise
2021-08-10
6:56 pm
N/A
2031-02-03
Poseida Therapeutics Inc. PSTX Ostertag Eric
CEO
10% Owner
111,149 $0 10,392,835
(Direct)
View
2021-08-06
Exercise
2021-08-10
6:56 pm
N/A
N/A
Poseida Therapeutics Inc. PSTX Ostertag Eric
CEO
10% Owner
111,149 $9.15 10,392,835
(Direct)
View
2021-08-20
Exercise
2021-08-24
5:12 pm
N/A
2026-06-19
Poseida Therapeutics Inc. PSTX Spear Matthew A.
Chief Medical Officer
4,000 $0 132,346
(Direct)
View
2021-08-20
Exercise
2021-08-24
5:12 pm
N/A
N/A
Poseida Therapeutics Inc. PSTX Spear Matthew A.
Chief Medical Officer
4,000 $1.322 132,346
(Direct)
View
2021-08-25
Option Award
2021-08-27
5:08 pm
N/A
2031-08-24
Poseida Therapeutics Inc. PSTX Corning Luke
Director
45,833 $0 45,833
(Direct)
View
2021-09-09
Exercise
2021-09-10
4:19 pm
N/A
2026-06-19
Poseida Therapeutics Inc. PSTX Spear Matthew A.
Chief Medical Officer
10,000 $0 132,346
(Direct)
View
2021-09-09
Exercise
2021-09-10
4:19 pm
N/A
N/A
Poseida Therapeutics Inc. PSTX Spear Matthew A.
Chief Medical Officer
10,000 $1.322 132,346
(Direct)
View
2021-09-13
Exercise
2021-09-15
6:58 pm
N/A
2026-02-28
Poseida Therapeutics Inc. PSTX Ostertag Eric
CEO
10% Owner
21,281 $0 10,263,181
(Direct)
View
2021-09-13
Exercise
2021-09-15
6:58 pm
N/A
N/A
Poseida Therapeutics Inc. PSTX Ostertag Eric
CEO
10% Owner
2,757 $1.173 10,263,181
(Direct)
View
2021-09-13
Exercise
2021-09-15
6:58 pm
N/A
N/A
Poseida Therapeutics Inc. PSTX Ostertag Eric
CEO
10% Owner
18,524 $9.15 10,263,181
(Direct)
View
2021-10-11
Exercise
2021-10-13
6:59 pm
N/A
2031-02-03
Poseida Therapeutics Inc. PSTX Ostertag Eric
CEO
10% Owner
18,525 $0 10,225,634
(Direct)
View
2021-10-11
Exercise
2021-10-13
6:59 pm
N/A
N/A
Poseida Therapeutics Inc. PSTX Ostertag Eric
CEO
10% Owner
18,525 $9.15 10,225,634
(Direct)
View
2021-11-01
Option Award
2021-11-02
7:31 pm
N/A
2031-10-31
Poseida Therapeutics Inc. PSTX Mylet Johanna
CFO
65,000 $0 93,515
(Direct)
View
2021-11-19
Exercise
2021-11-22
7:50 pm
N/A
2031-02-03
Poseida Therapeutics Inc. PSTX Ostertag Eric
CEO
10% Owner
1,000 $0 10,206,710
(Direct)
View
2021-11-19
Exercise
2021-11-22
7:50 pm
N/A
N/A
Poseida Therapeutics Inc. PSTX Ostertag Eric
CEO
10% Owner
1,000 $9.15 10,206,710
(Direct)
View
Goto 0, 1, Next